IL-1 Beta Inhibitors (Auburn University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIL-1 Beta Inhibitors (Auburn University)
Drug Alias Namealpha defensins (Auburn University)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-1 beta inhibitors
TargetsInterleukin-1 beta
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAuburn University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAuburn University
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A